Connect with us

Utah

Toxic waste shipped from Grand County concerns Utah residents

Published

on


The White Mesa Uranium Mill refines uranium-bearing product from a number of websites around the U.S., consisting of Moffat Passage.
Tim Peterson/EcoFlight

Considering That 2019, The Union Pacific Railway Co. has actually been delivering uranium-laden waste from the Moffat Passage water therapy plant in Winter season Park to Utah’s White Mesa Uranium Mill, which, according to Chairman Manuel Heart of the Ute Hill Ute People, endangers the alcohol consumption water his neighborhood relies on.

On March 15, 2022, agents from the Ute Hill Ute People, the Bears Ears Intertribal Union, the Grand Canyon Trust fund, as well as 2 U.S. congressmen fulfilled by means of Zoom to review the danger White Mesa Uranium Mill postures to the risk-free alcohol consumption water of the area. White Mesa is connected not just to Union Pacific’s therapy plant constructed near Winter season Park Ski Hotel, however to the poisonous mine drainage created by Moffat Passage.

Advertisement

A faster way with the hills with a high ecological rate

In 1927, the USA Federal Government as well as Union Pacific blew up Moffat Passage right into presence. The passage’s key goal was to reduce the trip in between Denver as well as Salt Lake City, as well as later on to pipeline fresh water from the Colorado River Container to the expanding populace of Denver as well as the Front Array.



Yet the building of Moffat Passage resulted in unforeseen effects; specifically the drainage of hefty steel- as well as uranium-rich water straight right into the Fraser River.

The procedure is rather straightforward: water from rainfall as well as snow atop the Continental Separate percolates with the high Towering expanse, down with cracks as well as fractures in the granite listed below, as well as ultimately out with openings such as old mine shafts as well as railway passages. In the process, the water grabs trace quantities of hefty steels, such as uranium. The water that departures the hills by means of drain factors like Moffat Passage is filled with these aspects.

Advertisement



For practically a century (from Moffat Passage’s building in the 1920s to 2014), Union Pacific had actually been discarding this polluted water straight right into the Fraser River. In 2014, after pushback by worried participants of the Grand Area neighborhood, Union Pacific as well as the Grand Area Board of Commissioners specified in a main news release that a center would certainly be constructed to strain “the great particulates as well as steels that have actually traditionally been released as contaminants to the Fraser River.”

The plant, created in 2017, was constructed appropriate alongside the base town of Winter season Park Hotel, as well as filterings system the harmful products, consisting of contaminated uranium, from Moffat Passage’s wastewater. What’s left is a poisonous sludge, which is after that delivered off to Utah, where it is dealt with at White Mesa Mill.

The checkered past of Union Pacific as well as the Fraser River

In 2018, the Colorado Division of Public Wellness as well as Atmosphere’s Water Quality assurance Department pointed out the Union Pacific Railway Business for releasing right into the Fraser River.

Advertisement

According to the division’s searchings for, there were a number of circumstances where Union Pacific was discarding polluted water right into the Fraser River in between 2012 as well as 2016. On one circumstances in October of 2016, the division discovered that harmful water overruned the water therapy plant’s diversion dam “over ground as well as straight right into the Fraser River.” Though the accurate variety of gallons that streamed right into the Fraser River at the spill’s elevation still continues to be vague, it’s approximated that “the water circulation right into the Fraser River varied from 164 to 387 gallons per min.”

Participants of the Ute Hill Ute People march against the uranium therapy mill in White Mesa, which can be intimidating their water.
Tim Peterson/Courtesy Picture

The Colorado Division of Public Wellness as well as Atmosphere discovered that Union Pacific had not just fell short to adhere to the state’s discharge demands defined in the 2008 Colorado Discharge Authorization System, however had actually additionally stopped working to “adhere to fundamental surface area water demands,” to “inform an adjustment in discharge,” as well as “correctly screen as well as record” the discharge Moffat Passage created.

Considering That 2018, Union Pacific has actually tidied up its act, as well as the Fraser River has actually been saved from having actually poisonous water released right into it. However despite the therapy plant getting rid of contaminants from the passage’s discharge water, the unsafe product left over after the water is dealt with needs to go someplace.

The Ute Hill Ute People as well as White Mesa Uranium Mill

In April of 2020, Union Pacific sent out a demand to the State of Utah Division of Environmental High Quality Department of Waste Administration as well as Radiation Control to increase the White Mesa Uranium Mill’s ability to consist of uranium-bearing product from the Moffat Passage therapy plant.

Advertisement

This demand defined that the product from Moffat Passage be dealt with at White Mesa as an “alternating feed”, which the USA Nuclear Regulatory Compensation specifies as “specific wastes, consisting of sludges or dirts, from various other websites which contains recoverable quantities of uranium.”

In the technological assessment as well as ecological evaluation for the Moffat Passage alternating feed demand, Union Pacific approximated that “the Moffat Passage uranium birthing product has a uranium material varying from 0.45 to 0.49 completely dry weight % all-natural uranium or 0.53 to 0.58 completely dry weight % [triuranium octoxide].”

According to the Epa, hefty steels as well as contaminated aspects can be destructive to individuals, as well as can possibly create cancer cells or abnormality. That’s why it’s bad information for pets, plants as well as individuals if these poisonous materials go into the marshes, rivers as well as groundwater.

That’s additionally why the Ute Hill Ute People, the city of Blanding, Utah, as well as the Bears Ears Intertribal Union are so worried that even more contaminated waste is being refined at the White Mesa Uranium Mill. The White Mesa Mill has actually been dealing with Uranium waste for years, as well as has actually run near the White Mesa Ute neighborhood. In 2021, the state of Utah authorized White Mesa’s application to refine the waste from Moffat Passage.

Throughout the March 15 conference, Manuel Heart, the Chairman of the Ute Hill Ute people, specified that there are “250 tribal, neighborhood, as well as staff members of the Ute Hill Ute People living (in White Mesa)” that obtain their water from the big aquifer that depends on the geological development under the mill.

Advertisement

Chairman Heart described that the poisonous or contaminated waste being dealt with at White Mesa (consisting of that from Moffat Passage), postures an extreme danger, as a result of poor precaution avoiding poisonous as well as contaminated product from seeping from White Mesa’s therapy fish ponds as well as right into the aquifer.

“Our issue from the Ute Hill Ute People,” claimed Chairman Heart, “is exactly how do we shield our tribal participants’ accessibility to tidy water?”

This is a difficult concern for the neighborhoods of the Ute Hill Ute People as well as the city of Blanding. An additional layer of intricacy is included when thinking about that a part of the waste adding to this danger comes right from the spacious mouth of Moffat Passage.

The neighborhoods of Grand Area, Blanding as well as White Mesa are confronted with the obstacle of exactly how to handle these harmful products, as well as exactly how to shield fresh alcohol consumption water. However with entities like White Mesa Mill as well as the Union Pacific Railway unintentionally developing a big quantity of poisonous as well as contaminated waste, it’s unidentified exactly how these neighborhoods will certainly handle this obstacle.

 

Advertisement



Source link

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Utah

Utah Jazz NBA Draft Preview: 2024

Published

on

Utah Jazz NBA Draft Preview: 2024


The Utah Jazz have an exciting night tomorrow because they have the 10th, 29th, and 32nd pick in the 2024 NBA Draft. the Jazz have been in several rumors regarding the draft. Some rumors suggest the Jazz will trade up for higher than pick number 10. Some rumors suggest the Jazz will package picks 29 and 32 for a higher second pick in the first round. The honest observation at this point is that the Jazz might do just about anything for the draft. Tune in tomorrow night from home or from the Delta Center to find out what the Jazz do in round one! To watch the draft, tune in to ABC or ESPN.

Round One Draft: 6 PM MST, June 26th

Round Two Draft: 2 PM MST, June 27th

Below are projections on who the Jazz could select with their 3 picks. The projections are based on the Jazz’s rumored interest and generally where players are projected to be picked.

10th Pick Projections:

Advertisement

Photo by David Becker/NBAE via Getty Images

Advertisement

Ron Holland

Nikola Topic

Rob Dillingham

Cody Williams

Zach Edey

Advertisement

Dalton Knecht

2024 NBA Combine

Advertisement

Photo by Kamil Krzaczynski/NBAE via Getty Images

29th Pick Projections:

Advertisement
2024 NBA Combine

Photo by Jeff Haynes/NBAE via Getty Images

Advertisement

Kyshawn George

Ryan Dunn

Baylor Scheierman

AJ Johnson

Justin Edwards

Advertisement

Cam Christie

Tyler smith

Johnny Furphy

Advertisement
Notre Dame v Virginia

Photo by Ryan M. Kelly/Getty Images

Advertisement

Pick 32 Projections:

2024 NBA Combine

Advertisement

Photo by Jeff Haynes/NBAE via Getty Images

Picks 29 and 32 are close so these projections mainly overlap.

Harrison Ingram

Kyle Flipowski

Advertisement

Trentyn Flowers

Jonathan Mogbo

Jaylon Tyson

Tyler Kolek

Bronny James

Advertisement

Bobi Klintman

2024 NBA Combine

Advertisement

Photo by Kamil Krzaczynski/NBAE via Getty Images

Final Prediction

This projection could be way off because this draft has a lot of parity and the Jazz could very well trade some of their picks. With that said, I predict that the Jazz select Nikola Topic with the 10th pick. For the 29th pick, The Jazz go for Ryan Dunn. For the 32nd pick, I predict that the Jazz select Jaylon Tyson. I think the Jazz will almost make a trade or two tomorrow but don’t quite pull the trigger.

Advertisement

Houston Rockets v Utah Jazz

What do you think the Jazz will do tomorrow night? Comment below!



Source link

Advertisement
Continue Reading

Utah

4 Utah Jazz rumors to watch before the NBA Draft

Published

on

4 Utah Jazz rumors to watch before the NBA Draft


The Tribune’s Andy Larsen breaks down the latest reports.

(Francisco Kjolseth | The Salt Lake Tribune) Brooklyn Nets forward Mikal Bridges (1) tries to evade the block attempt by Utah Jazz center Walker Kessler (24) during NBA basketball in Salt Lake City Monday, Dec. 18, 2023.

The NBA Draft starts Wednesday, and the rumor mill is heating up around the Utah Jazz. Here’s the latest news, along with my reaction to the possibilities.

Trading for Mikal Bridges?

Rumor: Yahoo’s Jake Fischer reported that the Jazz are one of the teams interested in trading for Brooklyn wing Mikal Bridges, along with Houston and New York. Bridges is one of “Utah’s most aggressive aspirations,” Fischer wrote.

Advertisement

Reaction: The Nets have repeatedly declined to trade Bridges despite it probably making sense for the franchise to do so. Instead, they’ve been asking for more than three first-round picks in return for the 27-year-old.

Bridges would make the Jazz significantly better; he’s developed himself into a 20-point-per-game scorer while also being a solid defender. He’s the two-way player with size that these most recent playoffs have shown are extremely valuable. (Though we should note here that he was a far better player before the All-Star break than after it last year.)

The problem is that it’s not immediately clear that the Jazz would be a playoff team even with Bridges — he was an eight-win player last season, and the Jazz finished 15 wins short of the No. 10 seed. For an acquisition of Bridges to make sense, Utah would probably need to acquire other good players around him and Lauri Markkanen to get up in that 45-win range required to make the playoffs in the West. Still, it could be an exciting first step.

Trading for Zach LaVine?

Rumor: The Bulls “remain active” on trade negotiations sending out Zach LaVine involving the Jazz and the Philadelphia 76ers, according to NBC Sports Chicago’s K.C. Johnson. However, reporter Marc Stein disagreed with the report, saying he had been “advised to dismiss Utah’s interest.”

Reaction: Johnson’s a quality veteran reporter, but I agree with Stein. While I haven’t heard recent updates, Jazz personnel earlier this year indicated that LaVine wasn’t a logical option in the pre-trade deadline market given the Jazz’s place in the standings, LaVine’s poor record of availability, and especially his high contract that pays him a combined $138 million over the next three years.

Advertisement

Chicago Bulls’ Zach LaVine (8) scores past Toronto Raptors’ Gary Trent Jr. (33) during the first half of an NBA basketball In-Season Tournament game Friday, Nov. 24, 2023, in Toronto. (Frank Gunn/The Canadian Press via AP)

I don’t suspect circumstances have changed enough since to make a LaVine trade make sense now, at least not a trade in which the Jazz are giving up assets. If anything, it might require Chicago to send out assets to push the Jazz to take on LaVine’s deal.

Signing Tobias Harris?

Rumor: The Athletic’s Shams Charania reported that the Jazz and the Detroit Pistons “are expected to be the strongest suitors for Tobias Harris,” who is a free agent this summer after his 5-year, $180 million albatross of a deal ended with the 76ers.

Reaction: The Jazz will likely have about $40 million in cap space this summer. Some of that room the franchise anticipates using on Markkanen’s renegotiation and extension as the Finnish star enters the final year of his current contract.

Boston Celtics’ Al Horford (42) defends against Philadelphia 76ers’ Tobias Harris (12) during the first half of an NBA basketball game Friday, Dec. 1, 2023, in Boston. (AP Photo/Michael Dwyer)

Advertisement

Harris is theoretically someone who could help the Jazz. At this point in his career, he’s statistically pretty average across the board — his shooting, rebounding, passing, steals, and block rates are just around the 50th percentile, maybe a bit higher. Even average, though, would make Harris the Jazz’s best wing by a lot.

He turns 32 this summer, so Harris doesn’t make sense for the Jazz’s long-term future, and signing him would also mean fewer minutes for last year’s No. 9 pick, Taylor Hendricks. But if they could get him on a short-term deal for a discount, he could also be a tradable piece in a move later while helping the Jazz improve now.

Looking to move up?

Rumor: Multiple reporters indicated that the Jazz are looking to move up in the draft using the No. 29 pick and the No. 32 pick. First, ESPN’s Jonathan Givony reported Monday morning that the Jazz are looking to trade the two picks for a “pick in the late teens.” Arizona sports radio host John Gambadoro reported that he believed that the Suns had had discussions with the Jazz, sending the No. 22 pick to Utah for No. 29 and No. 32. Fischer, meanwhile, floated the idea of the Jazz acquiring No. 17 from the Lakers in exchange for the two picks.

Reaction: Jazz general manager Justin Zanik acknowledged that the club has reservations about having six first- or second-year players on the roster next season, the logical outcome if the team makes all three selections on Wednesday. So the Jazz consolidating these picks in this fashion follows that line of thinking, especially if they are targeting a player they believe is significantly better than what’s available around the turn of the draft.

My only concern is that, in general, teams trading up in drafts get a little less value than those trading down when you study the issue analytically. The NBA Draft Pick Trade Simulator at nbasense.com is a good tool for looking at this — trading No. 29 and No. 32 for No. 17 is a pretty fair deal, but trading those picks for No. 22 would be analytically a bad idea. That’s especially true in a “flat” draft, where players’ values are considered pretty close throughout the first round.

Advertisement

If the Jazz are going to defy the analytics, they should be really sure that the player they’re acquiring with the higher pick is worth giving up two chances to place bets further down in the draft.

Editor’s note • This story is available to Salt Lake Tribune subscribers only. Thank you for supporting local journalism.



Source link

Continue Reading

Utah

Comparing TriSalus Life Sciences (NASDAQ:TLSI) and Utah Medical Products (NASDAQ:UTMD)

Published

on

Comparing TriSalus Life Sciences (NASDAQ:TLSI) and Utah Medical Products (NASDAQ:UTMD)



TriSalus Life Sciences (NASDAQ:TLSI – Get Free Report) and Utah Medical Products (NASDAQ:UTMD – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings and valuation.

Profitability

This table compares TriSalus Life Sciences and Utah Medical Products’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
TriSalus Life Sciences N/A N/A -221.65%
Utah Medical Products 33.40% 13.06% 12.30%

Risk & Volatility

TriSalus Life Sciences has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Comparatively, Utah Medical Products has a beta of 0.14, meaning that its stock price is 86% less volatile than the S&P 500.

Advertisement

Analyst Recommendations

This is a summary of recent ratings and recommmendations for TriSalus Life Sciences and Utah Medical Products, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TriSalus Life Sciences 0 0 3 0 3.00
Utah Medical Products 0 0 0 0 N/A

TriSalus Life Sciences presently has a consensus target price of $13.33, indicating a potential upside of 129.10%. Given TriSalus Life Sciences’ higher probable upside, research analysts plainly believe TriSalus Life Sciences is more favorable than Utah Medical Products.

Earnings & Valuation

This table compares TriSalus Life Sciences and Utah Medical Products’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
TriSalus Life Sciences $21.98 million 7.19 -$59.04 million N/A N/A
Utah Medical Products $50.22 million 4.68 $16.64 million $4.50 14.79

Utah Medical Products has higher revenue and earnings than TriSalus Life Sciences.

Advertisement

Institutional and Insider Ownership

2.6% of TriSalus Life Sciences shares are held by institutional investors. Comparatively, 69.6% of Utah Medical Products shares are held by institutional investors. 76.2% of TriSalus Life Sciences shares are held by insiders. Comparatively, 6.6% of Utah Medical Products shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Utah Medical Products beats TriSalus Life Sciences on 6 of the 11 factors compared between the two stocks.

About TriSalus Life Sciences

(Get Free Report)

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.

About Utah Medical Products

(Get Free Report)

Advertisement

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATHNUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women’s health centers in hospitals, outpatient clinics, and physician’s offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.



Receive News & Ratings for TriSalus Life Sciences Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for TriSalus Life Sciences and related companies with MarketBeat.com’s FREE daily email newsletter.

Advertisement



Source link

Continue Reading

Trending